These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

353 related articles for article (PubMed ID: 9450622)

  • 1. Matrix metalloproteinases in skin.
    Kähäri VM; Saarialho-Kere U
    Exp Dermatol; 1997 Oct; 6(5):199-213. PubMed ID: 9450622
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Matrix metalloproteinases in tumor progression: focus on basal and squamous cell skin cancer.
    Kerkelä E; Saarialho-Kere U
    Exp Dermatol; 2003 Apr; 12(2):109-25. PubMed ID: 12702139
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Matrix metalloproteinases in squamous cell carcinoma.
    Johansson N; Kähäri VM
    Histol Histopathol; 2000 Jan; 15(1):225-37. PubMed ID: 10668212
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Collagenases and tissue inhibitors of metalloproteinases: a functional balance in tissue degradation.
    Reynolds JJ
    Oral Dis; 1996 Mar; 2(1):70-6. PubMed ID: 8957940
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Complex role of matrix metalloproteinases in angiogenesis.
    Sang QX
    Cell Res; 1998 Sep; 8(3):171-7. PubMed ID: 9791730
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Extracellular matrix -- from basic research to clinical significance. An overview with special consideration of matrix metalloproteinases].
    Hamacher S; Matern S; Roeb E
    Dtsch Med Wochenschr; 2004 Sep; 129(38):1976-80. PubMed ID: 15375740
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tissue inhibitors of matrix metalloproteinases in cancer.
    Blavier L; Henriet P; Imren S; Declerck YA
    Ann N Y Acad Sci; 1999 Jun; 878():108-19. PubMed ID: 10415723
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stromelysin-3 (ST-3): immunohistochemical characterization of the matrix metalloproteinase (MMP)-11 in benign and malignant skin tumours and other skin disorders.
    Thewes M; Worret WI; Engst R; Ring J
    Clin Exp Dermatol; 1999 Mar; 24(2):122-6. PubMed ID: 10233668
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Focalized matrix proteolysis and inflammation].
    Gaudin P; Trocmé C; Monier F; Zaoui P; Barro C; Polack B; Hadjian A; Berthier S; Morel F
    Ann Biol Clin (Paris); 1998; 56(6):661-9. PubMed ID: 9853025
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human dermal microvascular endothelial cells produce matrix metalloproteinases in response to angiogenic factors and migration.
    Cornelius LA; Nehring LC; Roby JD; Parks WC; Welgus HG
    J Invest Dermatol; 1995 Aug; 105(2):170-6. PubMed ID: 7543547
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Matrix metalloproteinase inhibitors.
    Wojtowicz-Praga SM; Dickson RB; Hawkins MJ
    Invest New Drugs; 1997; 15(1):61-75. PubMed ID: 9195290
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Role of matrix-degrading enzymes in melanoma progression].
    Hofmann UB; Becker JC; Bröcker EB
    Hautarzt; 2002 Sep; 53(9):587-95. PubMed ID: 12207262
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Matrix metalloproteinases (MMPs) and their physiological inhibitors (TIMPs) are differentially expressed during excisional skin wound repair.
    Madlener M; Parks WC; Werner S
    Exp Cell Res; 1998 Jul; 242(1):201-10. PubMed ID: 9665817
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Matrix metalloproteinases involvement in pathologic conditions.
    Amălinei C; Căruntu ID; Giuşcă SE; Bălan RA
    Rom J Morphol Embryol; 2010; 51(2):215-28. PubMed ID: 20495735
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Matrix metalloproteinases and their expression in mammary gland.
    Uria JA; Werb Z
    Cell Res; 1998 Sep; 8(3):187-94. PubMed ID: 9791732
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of MMPS, MT-MMP, and TIMPs in squamous cell carcinoma of the oral cavity: correlations with tumor invasion and metastasis.
    Kurahara S; Shinohara M; Ikebe T; Nakamura S; Beppu M; Hiraki A; Takeuchi H; Shirasuna K
    Head Neck; 1999 Oct; 21(7):627-38. PubMed ID: 10487950
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of matrix metalloproteinases in melanoma cell invasion.
    Hofmann UB; Houben R; Bröcker EB; Becker JC
    Biochimie; 2005; 87(3-4):307-14. PubMed ID: 15781317
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Matrix metalloproteinases. Novel targets for directed cancer therapy.
    Yu AE; Hewitt RE; Connor EW; Stetler-Stevenson WG
    Drugs Aging; 1997 Sep; 11(3):229-44. PubMed ID: 9303281
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The membrane tethered matrix metalloproteinase MT1-MMP at the forefront of melanoma cell invasion and metastasis.
    Thakur V; Bedogni B
    Pharmacol Res; 2016 Sep; 111():17-22. PubMed ID: 27221755
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tissue inhibitors of metalloproteinases (TIMPs): their biological functions and involvement in oral disease.
    Verstappen J; Von den Hoff JW
    J Dent Res; 2006 Dec; 85(12):1074-84. PubMed ID: 17122157
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.